See more : Northern Lights Acquisition Corp. (NLIT) Income Statement Analysis – Financial Results
Complete financial analysis of Bright Health Group, Inc. (BHG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bright Health Group, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
You may be interested
- Trinity Industrial Corporation (6382.T) Income Statement Analysis – Financial Results
- Falcon Brighter Future (FIIFBF.CO) Income Statement Analysis – Financial Results
- Hebei Huijin Group Co., Ltd. (300368.SZ) Income Statement Analysis – Financial Results
- Tactical Resources Corp. (USREF) Income Statement Analysis – Financial Results
- Coenzyme-A Inc. (PPII) Income Statement Analysis – Financial Results
Bright Health Group, Inc. (BHG)
About Bright Health Group, Inc.
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 2.41B | 4.03B | 1.21B | 280.67M | 130.63M |
| Cost of Revenue | 1.28B | 2.21B | 3.95B | 1.05B | 224.39M | 96.41M |
| Gross Profit | -122.92M | 205.79M | 75.72M | 160.02M | 56.29M | 34.23M |
| Gross Profit Ratio | -10.59% | 8.53% | 1.88% | 13.25% | 20.05% | 26.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 7.24M | 2.54M |
| General & Administrative | 0.00 | 501.84M | 626.36M | 211.75M | 104.22M | 54.48M |
| Selling & Marketing | 0.00 | 82.34M | 287.76M | 96.94M | 49.71M | 26.75M |
| SG&A | 0.00 | 584.18M | 914.11M | 308.69M | 153.93M | 81.23M |
| Other Expenses | 1.74B | 98.28M | 359.76M | 89.50M | 20.45M | 13.09M |
| Operating Expenses | 1.74B | 682.46M | 1.27B | 417.62M | 181.62M | 96.87M |
| Cost & Expenses | 3.02B | 2.89B | 5.23B | 1.46B | 406.01M | 193.27M |
| Interest Income | 0.00 | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.96M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 24.17M | 51.36M | 36.71M | 8.29M | 1.13M | 1.03M |
| EBITDA | -1.15B | -425.31M | -1.16B | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -98.68% | -17.63% | -28.82% | -20.65% | -44.25% | -47.16% |
| Operating Income | -627.74M | -476.67M | -1.20B | -257.60M | -125.34M | -62.64M |
| Operating Income Ratio | -54.08% | -19.76% | -29.74% | -21.34% | -44.66% | -47.95% |
| Total Other Income/Expenses | -1.43M | -157.61M | -861.96M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -634.29M | -1.20B | -257.60M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -26.30% | -29.90% | -21.34% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.68M | -26.52M | -9.16M | 8.35M | 3.51M |
| Net Income | -1.20B | -637.97M | -1.18B | -248.44M | -133.69M | -62.64M |
| Net Income Ratio | -103.43% | -26.45% | -29.24% | -20.58% | -47.63% | -47.95% |
| EPS | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk,...
Bright Health Group Adopts NeueHealth as Corporate Brand Name
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable...
Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan,...
Bright Health Group receives approval for California Medicare sale; repays secured debt
Bright Health Group (BHG) Inc announced on Friday that it has received all necessary regulatory approvals to sell its California Medicare Advantage business to Molina Healthcare, with the acquisition expected to close in early January. In June, Molina agreed to...
Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final repayment amount...
BRIGHT HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Bright Health Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bright Health Group, Inc. (NYSE: BHG) on behalf of long-term stockholders following a class action complaint that was filed against...
Bright Health Group, Inc. (BHG) Q3 2023 Earnings Call Transcript
Bright Health Group, Inc. (NYSE:BHG ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Stephen Hagan - Investor Relations Director Mike Mikan - Vice Chairman, CEO & President Jay Matushak - CFO Conference Call Participants...
Bright Health Group Reports Third Quarter 2023 Results
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its Third Quarter ended September 30, 2023. “Bright...
Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at...
Bright Health Group Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down
MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company, today announced it continues to make progress on the wind-down of its ACA insurance business. The Company has made significant progress paying...
Source: https://incomestatements.info
Category: Stock Reports